This federal contract award, with ID SPE2DB25D7055|SPE2DB25FXYHW, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,820.66 firm fixed-price delivery order is for DEXCOM G7 SENSORS, a medical device product. The contract has an ultimate completion date of March 28, 2025 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $2,009.80, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of DEXCOM G7 SENSORS, a medical device used for glucose monitoring, with a completion date of December 30, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,031.20, is for the delivery of DEXCOM G7 SENSORS and has an ultimate completion date of April 10, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,119, is for the delivery of DEXCOM G7 SENSORS, a type of medical device, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of January 9, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FA9X8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a medical device used for diabetes management, with a ceiling value of $2,752.46 and a performance period through March 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the supply of DEXCOM G7 SENSORS, a medical device product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,708.46 and an ultimate completion date of January 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the delivery of DEXCOM G7 SENSORS, a medical device, to the Defense Logistics Agency (DLA), a defense agency. The $1,064.94 delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 16, 2025 with a completion date of April 17, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $2,464.05, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a type of medical device, with a completion date of July 1, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designations. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $1,408.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for DEXCOM G7 SENSORS, a medical device, with a performance period extending until April 16, 2025. This contract is not set aside and is a firm fixed-price agreement. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with an ID of SPE2DB20D3303|SPE2DB24FA0HS, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,636.15 firm fixed-price delivery order is for the procurement of DEXCOM G7 SENSORS, which are likely medical devices or supplies. The contract has an ultimate completion date of June 26, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...